Sunesis Announces Data of Ongoing Vosaroxin Study at ASCO
April 22, 2014 at 07:09 AM EDT
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that updated data from the ongoing Phase 1b/2 University of Texas MD ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.